D.E. Shaw & Co
NERV icon

D.E. Shaw & Co’s Minerva Neurosciences NERV Stock Holding History

D.E. Shaw & Co’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,419
Closed -$76K – 5617
2022
Q1 		$76K Sell
11,419
-1,101
-9% -$6.75K ﹤0.01% 5052
2021
Q4 		$80K Sell
12,520
-11,237
-47% -$106K ﹤0.01% 5114
2021
Q3 		$331K Sell
23,757
-15,950
-40% -$240K ﹤0.01% 4304
2021
Q2 		$737K Buy
39,707
+28,064
+241% +$604K ﹤0.01% 3788
2021
Q1 		$272K Sell
11,643
-958
-8% -$23.9K ﹤0.01% 3745
2020
Q4 		$236K Buy
12,601
+9,087
+259% +$229K ﹤0.01% 3676
2020
Q3 		$89K Sell
3,514
-9,482
-73% -$256K ﹤0.01% 3715
2020
Q2 		$375K Buy
+12,996
New +$762K ﹤0.01% 3528
2019
Q4 		– Sell
-2,037
Closed -$126K – 4105
2019
Q3 		$126K Sell
2,037
-7,979
-80% -$452K ﹤0.01% 3679
2019
Q2 		$452K Sell
10,016
-3,659
-27% -$183K ﹤0.01% 3122
2019
Q1 		$860K Buy
13,675
+2,276
+20% +$137K ﹤0.01% 2692
2018
Q4 		$614K Buy
11,399
+4,282
+60% +$313K ﹤0.01% 2976
2018
Q3 		$714K Buy
+7,117
New +$535K ﹤0.01% 2899
2017
Q3 		– Sell
-5,616
Closed -$398K – 3550
2017
Q2 		$398K Buy
5,616
+2,349
+72% +$152K ﹤0.01% 2908
2017
Q1 		$212K Buy
+3,267
New +$254K ﹤0.01% 3103
2016
Q3 		– Sell
-6,099
Closed -$498K – 3485
2016
Q2 		$498K Buy
+6,099
New +$388K ﹤0.01% 2800

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

D.E. Shaw & Co's NERV Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Minerva Neurosciences (NERV) in Q2 2022, closing a stake of 11,419 shares — an estimated $76K sold.

D.E. Shaw & Co first reported a position in NERV in Q2 2016 and held it in 16 quarters. The position peaked at $860K in Q1 2019. 23 funds tracked by Wall St. Rank hold NERV as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Minerva Neurosciences position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 11,419 Minerva Neurosciences shares in Q2 2022, an estimated $76K.
  • D.E. Shaw & Co first reported a position in Minerva Neurosciences in Q2 2016 and held it in 16 quarters.
  • D.E. Shaw & Co's Minerva Neurosciences position peaked at $860K in Q1 2019.
  • 23 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.